AFJK
Aimei Health Technology Co., Ltd
NASDAQ · Financial Services · Shell Companies · US
$12.49
+2.34%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- +39.9%
- EPS
- -69.2%
- Free cash flow
- +45.0%
- Operating cash flow
- +45.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +21.5%
- EBIT
- +21.5%
- Net income
- +148.7%
- EPS
- +199.1%
- Free cash flow
- +15.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026